酪氨酸激酶抑制剂时代完全缓解状态下Ph染色体阳性急性淋巴细胞白血病异基因造血干细胞移植预后分析

OBJECTIVE: To study the clinical results and prognostic factors for allo-HSCT of Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia (ALL) in complete remission (CR) in the era of tyrosine kinase inhibitors (TKI). METHODS: We performed a retrospective analysis of the clinical chara...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449779/
https://www.ncbi.nlm.nih.gov/pubmed/32810963
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449779/
https://www.ncbi.nlm.nih.gov/pubmed/32810963
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.07.006

Ejemplares similares